Conference 2022

PIPA Conference 2022 – 28th & 29th September

Venue: Hogs Back Hotel, Farnham: https://www.suryahotels.co.uk/thehogsbackhotelspa/

Cost:

1 day: £500 + VAT 

2 day: £875 + VAT

Should you wish to attend the networking event and dinner on the evening of 28th September, there is an additional charge of £50 + VAT.

Fees include attendance to all scientific sessions, exhibitions, lunch, tea and coffee breaks, but does not include overnight accommodation or evening meals.

Booking: https://pipaonline.org/civicrm/event/info/?reset=1&id=25

We are delighted to announce that we will be returning to an in-person event for our 2022 PIPA Annual Conference. We will follow our traditional 2-day format with joint pharmacovigilance and medical information plenary sessions followed by PV, MI and Code Compliance presentations and workshops running in parallel. We will also be offering a range of workshops relevant to MI, PV and Code Compliance professionals, as well as an afternoon session specifically tailored for managers in this field.

As always, we are inviting experienced speakers to deliver a dynamic and topical programme of sessions across the two days.

PIPA Conference 2022 Programme

Wednesday 28th September

Plenary

09:00 Registration, Meet & Greet Breakfast
09:55 Introduction 
Tom Nichols, PIPA President
10:15 Rising Stronger – from Mental Health to Mental Wealth
Suzie Lavington, Art of Brilliance
11:15 Comfort Break
11:30 AGM
12:00 Northern Ireland Protocol and Brexit
John Barber, Plain Pharma Consulting
Six years on from the Brexit referendum and 18 months from EU Exit Day yet the implications for pharmacovigilance have not been fully resolved. The main stumbling block is the special situation of Northern Ireland as enshrined in the Good Friday/Belfast Agreement and the Northern Ireland Protocol. This session will review the current status and discuss some points to consider for MAHs trying to navigate the complex post-Brexit road map. This will include impacts on medicines and medical device registration, supply chain, medical information and pharmacovigilance.
13:00 Lunch & Exhibition

Breakout Sessions

14:00 A. PV Vendor Management and Outsourcing
Saher Hussain, Roche
Keys to successful client- vendor partnerships: Getting it right from the start, troubleshooting and celebrating success!
B. Ensuring High-Quality Health Information for Patients and Members of the Public
Dan Wills, Patient Information Forum
C. Managers’ Workshop:
– Discussion: hybrid working – challenges for managers
Chris Isaacs & Kate Hellmuth, Novartis Pharmaceuticals UK Ltd
– Developing a feedback culture
Jonathan Hart-Smith, CK Group
15:15 Tea / Coffee & Exhibition
15:45 Break out sessions continued
17:00 Close
19:00 Pre-Dinner Drinks, Dinner and Evening Networking Event

Thursday 29th September

Track One: Medical Information

09:00 Is Your Medical Information Department Audit and Inspection Ready?
Janine Gavin-Poulter, Collaborative Pharma & Sanjay Motivaras, Audit PV
10:00 GDPR
Wendy Lloyd Goodwin, Life Science Law
11:00 Tea / Coffee & Exhibition
11:30 Hot Topics in Code Compliance
Jayne Packham, Jayne Packham Consultancy
12:15 Global and Local Copyright Considerations
Michael Healy, Copyright Clearance Center
13:00 Lunch & Exhibition

Track Two: Pharmacovigilance

09:00 Pharmacovigilance Monitoring and Automation in Social Media
10:00 Global PV Perspectives and Hot Topics – Round Table Discussion
Chairs: Stephanie Martin, SMPV Ltd; Janine Gavin-Poulter, Collaborative Pharma; Tom Nichols, DrivePhase PV
11:15

Tea / coffee & Exhibition

11:45 PV Systems Differences between Europe, US and APAC – focussing on Aggregate Reporting
Tom Nichols, DrivePhase PV
13:00 Lunch & Exhibition

Breakout Sessions

14:00 A. PV Agreements Optimisation
Dr Dave Lewis & Jean Kilgour-Christie, Novartis
The Pharmacovigilance Agreements (PVAs) workshop focuses on addressing foundational elements related to PVAs, such as:

  • Development, implementation, and maintenance of PVAs
  • Considerations for the table of contents and glossary for PVAs
  • Benchmarking data concerning exchange timelines for PVAs

We will not suggest a standard industry PVA template, nor provide recommendations pertaining to data exchange. Rather, this workshop will focus on a suite of customisable solutions for MAHs, which could be used to support all end-to-end PVA processes.

B. Medical Information Practices – how to be the best
Sarah Dunnett, Sarah Dunnett Consulting Ltd

In this interactive workshop we’ll explore how MI team members at all levels can optimise and advance their MI services.

We’ll explore a range of resources, models and exercises to facilitate discussion and learning on pertinent topics including Medical Information team dynamics, governance and sustainable quality, prioritisation, environmental factors, technology, impact and profile. Delegates will hear and develop tactics to enjoy successes and challenge themselves to ‘be the best’.

C. Good PV Practice – Mergers and Acquisitions, Divestments and Transitions
Irene Rebollo, Novartis

15:15 Tea / Coffee & Exhibition
15:45 Break out sessions continued
17:00 Close